← Eichor
Study identifier: NCT06094933 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Mobile Anger Reduction Intervention

Condition: Posttraumatic Stress Disorder · Anger  ·  Sponsor: VA Office of Research and Development

PhaseNA
Planned participants150
Who can joinAll sexes, N/A to no upper limit
Healthy volunteersNo

About this study

Difficulty controlling anger is the most commonly reported reintegration concern among combat Veterans, especially those with a diagnosis of posttraumatic stress disorder (PTSD). Problematic anger is associated with significant functional impairment. In the current project, the investigators will compare the Mobile Anger Reduction Intervention (MARI) with a health education mobile intervention (HED) among Veterans with PTSD and problematic anger. Participants will be randomized to the MARI or HED condition. The hypothesis is that participants in the MARI condition will experience greater anger reductions and functional improvements relative to the HED condition.

This description comes directly from the study's public registry record.

Talk to the study team

Kirsten H Dillon, PhD  ·  (919) 286-0411  ·  Kirsten.Dillon@va.gov

Angela C Kirby, MS  ·  (919) 286-0411  ·  angela.kirby@va.gov

Always discuss trial participation with your own doctor first.

Locations (1)

Durham VA Medical Center, Durham, NCDurham, North Carolina, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06094933